Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5928839 | American Heart Journal | 2013 | 13 Pages |
Abstract
EMBRACE-STEMI is testing the hypothesis that Bendavia, in conjunction with standard-of-care therapy, is superior to placebo for the reduction of myocardial infarction size among patients with first time, acute, anterior wall STEMI who undergo successful reperfusion with primary PCI and stenting.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Anjan K. MD, Kristin BS, Cassandra MPH, David A. PhD, Ewa MD, Michal MD, Andras MD, Robert P. MD, Robert A. MD, PhD, W. Douglas MD, Christoph MD, Jacek MD, Bela PhD, DSc, C. Michael MS, MD,